세계의 CRISPR 기술 시장 규모는 2023년 34억 달러, 2024년 38억 달러에서 예측 기간 중 14.4%의 CAGR로 추이하며, 2029년말에는 75억 달러 규모로 성장할 것으로 예측됩니다.
용도별로는 의약품 개발 용도 부문이 2024년 19억 달러에서 15.5%의 CAGR로 추이하며, 2029년에는 38억 달러로 성장할 것으로 예측됩니다. 농업 용도 부문이 2024년 10억 달러에서 14.2%의 CAGR로 추이하며, 2029년에는 20억 달러로 성장할 것으로 예측됩니다.
세계의 CRISPR 기술의 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 신규 기술 및 기술개발의 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
제2장 시장 개요
- 유전자 편집
- CRISPR
- CRISPR 컴포넌트
- 작용기서
- CRISPR 유전자 편집 워크플로우
- CRISPR 기술의 이점과 결점
- 가격 분석
- PESTLE 분석
- Porter's Five Forces 분석
- 규제 상황 : 유형별
- 인간
- 유전자 드라이브
- 농업
- 동물
- 규제 상황 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제3장 시장 역학
- 시장 역학 스냅숏
- 시장 성장 촉진요인
- 만성질환 발증률의 상승
- 유전성 질환의 유병률
- 정부와 민간 자금
- 시장 성장 억제요인
- 대체 기술
- 시장 기회
- 신청 건수의 증가
- 시장이 해결해야 할 과제
- 복잡하고 진화하는 규제 상황
- CRISPR 기반 치료의 고비용성
제4장 신규 기술과 개발
- 신규 기술
- CRISPR 생체내 송달
- 개량된 Cas 배리언트
- AI
- 임상시험 분석
- 임상시험 분석(연구 유형별)
- 임상시험 분석(현황별)
- 임상시험 분석(단계별)
- 임상시험
- 특허 분석
- 특허(연별)
- 특허(출원인별)
- 특허(주요 소유자별)
- 특허(관할별)
- 지적재산 분쟁·특허 문제
제5장 시장 세분화 분석
- 세분화 내역
- 시장 내역 : 용도별
- 의약품 개발
- 농업
- 진단
- 기타
- 시장 내역 : 최종사용자별
- 바이오테크놀러지·제약 기업
- 학술·정부 연구기관
- CRO
- 지역적 내역
- 시장 내역 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제6장 경쟁 정보
제7장 CRISPR 기술의 지속가능성 : ESG 관점
- ESG : 서론
- CRISPR 기술의 지속가능성 : ESG 관점
- 주요 ESG 문제
- CRISPR 기술 ESG 퍼포먼스 분석
- 환경 퍼포먼스
- 사회적 퍼포먼스
- 거버넌스 퍼포먼스
- BCC에 의한 결론
제8장 부록
- 조사 방법
- 참고 문헌
- 약어
- 기업 개요
- AGILENT TECHNOLOGIES INC.
- BEAM THERAPEUTICS
- CARIBOU BIOSCIENCES INC.
- CRISPR THERAPEUTICS
- DANAHER CORP.
- EDITAS MEDICINE
- GENSCRIPT
- INTELLIA THERAPEUTICS INC.
- LONZA
- MERCK KGAA
- THERMO FISHER SCIENTIFIC INC.
KSA
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
The global market for CRISPR technology in drug development application is expected to grow from $1.9 billion in 2024 to $3.8 billion by 2029, at a CAGR of 15.5% from 2024 to 2029.
The global market for CRISPR technology in agriculture application is expected to grow from $1.0 billion in 2024 to $2.0 billion by 2029, at a CAGR of 14.2% from 2024 to 2029.
Report Scope
This report on CRISPR technology provides market projections for 2029 and analyzes the market for CRISPR technology by application and end user. Applications covered include drug development, agriculture, diagnostics and others. End users include biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations.
Report Includes
- 32 data tables and 61 additional tables
- An analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology
- Analyses of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projected CAGRs through 2029
- Discussion of the market potential for CRISPR technology
- Estimate of the market size and a revenue forecast for the global CRISPR technology market, and a corresponding market share analysis by application, end user, and region
- Discussion of the major market dynamics, regulations, industry challenges, and macroeconomic factors that will affect the demand for CRISPR technology market over the next five years
- A look at the recent breakthrough in CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological research
- A comparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases
- Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology
- A discussion on ESG challenges and ESG practices of the industry participants
- A look at the proprietary technologies and strategic alliances of the companies best positioned in the CRISPR market
- Analysis of the industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19
- Company profiles of the major players, including Merck KGaA, Thermo Fisher Scientific, Beam Therapeutics, CRISPR Therapeutics and Danaher Corp.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Genome Editing
- CRISPR
- Introduction
- Components of CRISPR
- Mechanism of Action
- CRISPR Gene Editing Workflow
- Advantages and Disadvantages of CRISPR Technology
- Pricing Analysis
- PESTLE Analysis
- Porter's Five Forces Analysis
- Regulatory Landscape, by Type
- Human
- Gene Drives
- Agriculture
- Animals
- Regulatory Landscape, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Rising Incidence of Chronic Diseases
- Prevalence of Genetic Disorders
- Government and Private Funding
- Market Restraints
- Alternative Technologies
- Market Opportunities
- Increase in the Number of Applications
- Market Challenges
- Complex and Evolving Regulatory Landscape
- High Cost of CRISPR-based Therapy
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies
- In Vivo Delivery of CRISPR
- Improved Cas Variants
- Artificial Intelligence
- Clinical Trials Analysis
- Clinical Trials Analysis, by Type of Study
- Clinical Trials Analysis, by Status
- Clinical Trials Analysis, by Phase
- Clinical Trials
- Patent Analysis
- Patents, by Year
- Patents, by Top Applicant
- Patents, by Top Owner
- Patents, by Jurisdiction
- Intellectual Property Disputes and Patent Issues
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown, by Application
- Drug Development
- Agriculture
- Diagnostics
- Other Applications
- Market Breakdown, by End User
- Biotech and Pharmaceutical Companies
- Academics and Government Research Institutes
- Contract Research Organizations
- Geographic Breakdown
- Market Analysis, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Market Analysis
- Strategic Analysis
Chapter 7 Sustainability in CRISPR Technology: An ESG Perspective
- Introduction to ESG
- Sustainability in CRISPR Technology: An ESG Perspective
- Key ESG Issues
- CRISPR Technology ESG Performance Analysis
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
Chapter 8 Appendix
- Methodology
- References
- Abbreviations
- Company Profiles
- AGILENT TECHNOLOGIES INC.
- BEAM THERAPEUTICS
- CARIBOU BIOSCIENCES INC.
- CRISPR THERAPEUTICS
- DANAHER CORP.
- EDITAS MEDICINE
- GENSCRIPT
- INTELLIA THERAPEUTICS INC.
- LONZA
- MERCK KGAA
- THERMO FISHER SCIENTIFIC INC.
